KLOW
GHK-Cu / BPC-157 / TB-500 / Kojic Acid blend
An extended variant of the GLOW blend, adding kojic acid — a compound studied for tyrosinase-inhibiting activity — for research protocols examining pigmentation alongside dermal remodeling. Note for researchers: some suppliers sell a same-named 'KLOW' formulation built on GHK-Cu/BPC-157/TB-500/KPV instead of kojic acid — confirm which formulation a given comparison or literature reference is describing, since the name is not fully standardized across the supply market.
What researchers are studying KLOW for.
Pigmentation and Tyrosinase-Inhibition Research
Dermal Remodeling and Collagen Research
Combined Topical/Systemic Protocol Studies
GHK-Cu / BPC-157 / TB-500 / Kojic Acid blend
Concentration and unit math, worked out.
Worked example for a 20mg vial reconstituted with 3mL of bacteriostatic water, drawn on a U-100 insulin syringe. Use the calculator below for any other vial size or water volume.
| UNITS DRAWN | VOLUME | DELIVERS |
|---|---|---|
| 5 units | 0.05 mL | 333 mcg |
| 10 units | 0.10 mL | 667 mcg |
| 20 units | 0.20 mL | 1333 mcg |
| 30 units | 0.30 mL | 2000 mcg |
| 50 units | 0.50 mL | 3333 mcg |
Run your own numbers.
Pre-filled with a 30-day starting point — one vial, dosed once daily for 30 days. Adjust any field to match your own protocol.
RESULTS
Educational reference tool only — not medical advice. Reconstitution and dosing decisions for any research protocol should be reviewed with a qualified professional. Figures assume uniform mixing and standard syringe calibration; always verify against your own protocol.